Envision Healthcare Corporation (EVHC) Receives Average Rating of “Buy” from Analysts

Shares of Envision Healthcare Corporation (NYSE:EVHC) have been given an average recommendation of “Buy” by the fifteen ratings firms that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation, ten have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $75.43.

A number of equities analysts have recently weighed in on EVHC shares. BidaskClub raised shares of Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. Royal Bank Of Canada boosted their price objective on shares of Envision Healthcare Corporation from $72.00 to $77.00 and gave the company an “outperform” rating in a research report on Tuesday, June 27th. Zacks Investment Research raised shares of Envision Healthcare Corporation from a “strong sell” rating to a “buy” rating and set a $70.00 price objective for the company in a research report on Tuesday, July 4th. Cantor Fitzgerald reissued a “buy” rating and issued a $80.00 price objective on shares of Envision Healthcare Corporation in a research report on Tuesday, July 4th. Finally, Mizuho cut their price objective on shares of Envision Healthcare Corporation from $65.00 to $57.00 and set a “neutral” rating for the company in a research report on Wednesday, August 9th.

Shares of Envision Healthcare Corporation (NYSE EVHC) opened at 42.38 on Wednesday. The firm’s market cap is $4.96 billion. Envision Healthcare Corporation has a 12-month low of $42.27 and a 12-month high of $74.75. The firm has a 50-day moving average of $47.48 and a 200-day moving average of $55.16.

Envision Healthcare Corporation (NYSE:EVHC) last posted its quarterly earnings data on Monday, August 7th. The company reported $0.79 earnings per share for the quarter, beating analysts’ consensus estimates of $0.75 by $0.04. The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. The company’s revenue was up 156.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.34 earnings per share. On average, equities analysts forecast that Envision Healthcare Corporation will post $1.40 earnings per share for the current fiscal year.

Envision Healthcare Corporation declared that its Board of Directors has approved a stock repurchase program on Monday, September 18th that authorizes the company to buyback $250.00 million in shares. This buyback authorization authorizes the company to buy up to 4.5% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its stock is undervalued.

A number of hedge funds have recently modified their holdings of the stock. Lord Abbett & CO. LLC increased its position in Envision Healthcare Corporation by 259.6% during the second quarter. Lord Abbett & CO. LLC now owns 1,321,328 shares of the company’s stock worth $82,808,000 after purchasing an additional 953,928 shares during the last quarter. Phocas Financial Corp. increased its position in Envision Healthcare Corporation by 0.4% during the second quarter. Phocas Financial Corp. now owns 101,263 shares of the company’s stock worth $6,346,000 after purchasing an additional 427 shares during the last quarter. Toronto Dominion Bank increased its position in Envision Healthcare Corporation by 25.5% during the second quarter. Toronto Dominion Bank now owns 39,790 shares of the company’s stock worth $2,492,000 after purchasing an additional 8,091 shares during the last quarter. Sterling Capital Management LLC increased its position in Envision Healthcare Corporation by 3.5% during the second quarter. Sterling Capital Management LLC now owns 60,808 shares of the company’s stock worth $3,811,000 after purchasing an additional 2,084 shares during the last quarter. Finally, Nomura Holdings Inc. acquired a new position in Envision Healthcare Corporation during the second quarter worth approximately $797,000.

COPYRIGHT VIOLATION WARNING: “Envision Healthcare Corporation (EVHC) Receives Average Rating of “Buy” from Analysts” was first published by Week Herald and is the property of of Week Herald. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at https://weekherald.com/2017/10/11/envision-healthcare-corporation-evhc-receives-average-rating-of-buy-from-analysts.html.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply